Sugentech, Inc. is the 28th INNOPOLIS Research Institute Spin-off Company of Ministry of Science and ICT in Korea and was established in 2011 based on the technology transfer from the ETRI (Electronics and Telecommunications Research Institute).
Since its establishment, Sugentech has accumulated various and robust bio- and nano- based technologies and successfully commercialized a variety of in- vitro diagnostic products. In 2017, K-MAC(bio department), an outstanding Korean semiconductor company became a Sugentech family, while bringing its full automation and IT technology and finally together making a comprehensive in-vitro diagnostic company with whole converging bio, nano and IT technology.
Now we are developing and selling products that can diagnose many types of diseases based on various platforms such as self-diagnostics home testing products (Self-testing), Point-of-care testing(POCT) products for rapid and accurate diagnosis in small and medium hospitals, and Fully Automated Immunoblot system for multiplex testing at large hospitals.
Based on its internalized bio-nano-IT convergence technology and commercialization capability, Sugentech enables early diagnosis of diseases which were not possible before, and is opening a new era of a personalized diagnosis through the development of micro, multiplex, automated diagnostic instruments.